COURT-RULING ·Filed Mar 30, 2026
Court ruling (district)
Actionable Insight • Neutral
Monitor for subsequent filings or docket updates in this case for material developments; no immediate financial or operational impact can be assessed from current information.
Final — all horizons settled through T+60d
JNJ ▼ -0.55% at T+60d
NEUTRAL call ✗ call lost -0.55% · α vs SPY -16.58% · entry $242.34 → $241.00
T+1d
+0.84%
call +0.84% · α -2.05%
$244.38
settled 6mo ago
T+5d
-1.65%
call -1.65% · α -5.96%
$238.33
settled 6mo ago
T+20d
-6.06%
call -6.06% · α -18.66%
$227.65
settled 5mo ago
T+60d
-0.55%
call -0.55% · α -16.58%
$241.00
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable
Court Ruling Details
Court
United States District Court for the District of New Jersey
Court Level
District
Case Type
other
Ruling Type
other
Outcome
NULL
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW
Key Facts
- Case: Snyder et al v. Janssen Pharmaceuticals, Inc. et al
- Filed in United States District Court for the District of New Jersey on 2026-03-30
- Janssen Pharmaceuticals, Inc. is a subsidiary of Johnson & Johnson (JNJ)
Financial Impact
Unknown — no financial details available in provided documents
Risk Factors
- Potential for future adverse rulings if the case proceeds on product liability or marketing claims, which are common in pharmaceutical litigation
- Precedent risk if this case evolves into a class action or involves off-label promotion or opioid-related allegations
Market Snapshot
Price
$242.00
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
59% bullish (32 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-6k5omeby-JNJ |
16 reports for JNJ
60% Hit rate best @ T+60▲ +13.24%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | Court Ruling | $267.08 $267.28 | ▲ +0.07% | ▲ +0.73% | $258.66 (−3.15%) |
Aug 18, 2026 6w ago | Insider Cluster | $273.41 $270.00 | ▼ −1.25% | ▼ −0.86% | $258.66 (−5.39%) |
Aug 14, 2026 7w ago | Insider Cluster | $260.35 $270.24 | ▲ +3.80% | ▲ +5.17% | $258.66 (−0.65%) |
Aug 7, 2026 7w ago | Insider Cluster | $261.81 $262.37 | ▲ +0.21% | ▲ +0.26% | $258.66 (−1.20%) |
Aug 7, 2026 8w ago | Court Ruling | $259.24 $260.35 | ▼ −0.43% | ▼ −0.03% | $258.66 (+0.22%) |
Aug 4, 2026 8w ago | 8-K | $254.93 $259.80 | ▲ +1.91% | ▲ +2.01% | $258.66 (+1.46%) |
Jul 22, 2026 10w ago | Court Ruling | $255.63 $265.53 | ▼ −3.87% | ▼ −6.27% | $258.66 (−1.19%) |
Jul 15, 2026 11w ago | 8-K | $247.02 $255.63 | ▲ +3.49% | ▲ +4.47% | $258.66 (+4.71%) |
May 20, 2026 19w ago | Court Ruling | $229.12 $231.29 | ▲ +0.95% | ▼ −0.29% | $258.66 (+12.89%) |
May 13, 2026 20w ago | ANALYST-UPGRADE | $230.79 $231.58 | ▲ +0.34% | ▲ +1.06% | $258.66 (+12.08%) |
Showing 10 of 16
US Market Status
Market Closed — Opens in 40m
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access